Abstract P158: Depression After Cardiac Transplantation From 2012 to 2018 in a Reference Hospital in Recife: A Transversal Study

Abstract

Introduction: Cardiac transplantation represents a treatment opportunity for cardiovascular diseases that are refractory to traditional methods. For the procedure’s success, the individual needs to be collaborative and remain surrounded by restrictions and intensive care even after its performance. Thus, the emotional burden that surrounds the process contributes to depression after the surgery. The impact of depression on one’s quality of life has been subject of research all over the world, but its value is not completely clarified after a heart transplantation. Objective: To estimate the occurrence of symptoms of depression in 50 patients who underwent cardiac transplantation at the Institute of Integral Medicine Professor Fernando Figueira between 2012 and 2018. Hypothesis: Depression was a frenquent event after cardiac transplatation in the sample of this study. Methods: A cross-sectional observational study using questionnaires adapted, translated and validated in Brazil, the Medical Outcomes Study 36- Item Short-Form Health Survey (SF-36) for quality of life assessment and the Beck II Depression Inventory (BDI-II), for evaluation of depression symptoms. The collection was performed at the Cardiac Transplant Outpatient Clinic of the referred hospital, through individual interviews. The data collected was entered in the program Microsoft Excel version 2010 and the Statistical Package for the Social Sciences - SPSS 13.0 Software for Windows was used. All tests were applied with 95% confidence. This study is based on Resolution 466/2012 of the National Health Council. This research was approved in the Ethics Committee of the Institute of Integral Medicine Professor Fernando Figueira with CAAE n°66851517.7.0000.5201. Results: The sample consisted of 50 patients, 76% male (38 of 50), mean age of 47.76 years and 48% (24 of 50) had low education level. Data obtained by the application of BDI-II (n = 50) presented a mean of 13.36, median of 13.00, standard deviation of 12.76. Of the sample, 70% (35 of 50) were considered to have symptoms of depression, reaching scores with more than 9 points, the difference of genres being of little statistical significance. Among the variables related to the symptoms of depression, only the need for anxiolytic after transplantation was statistically relevant. In the comparison of the SF-36 with the 35 symptomatic patients for depression, of their eight scales only limitation by physical aspects and emotional aspects were not statistically relevant. Conclusion: The symptoms of depression could be verified in the sample with a significant impact on quality of life, when associated with functional capacity, pain, general health, vitality, social aspects and mental health. Patients who underwent heart transplantation should receive multidisciplinary care in order to minimize their vulnerabilities.